Title : Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy.

Pub. Date : 2021 Feb

PMID : 33421702






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 All but two patients with paradoxical reactions to lamotrigine were diagnosed with juvenile myoclonic epilepsy (JME), otherwise, the clinical and electroencephalographic characteristics of patients with paradoxical reactions did not differ. Lamotrigine myoclonic epilepsy, juvenile, 2 Homo sapiens
2 At treatment start, the estimated risk of a paradoxical reaction to lamotrigine was 7.9 % in JME patients (n = 190). Lamotrigine myoclonic epilepsy, juvenile, 2 Homo sapiens
3 JME), the estimated risk of clinically relevant seizure aggravation under treatment with lamotrigine was 3.7 % (1.8 % for zonisamide and 0.8 % for levetiracetam). Lamotrigine myoclonic epilepsy, juvenile, 2 Homo sapiens
4 In conclusion, clinical significant aggravation of seizure frequency is common in lamotrigine-treated JME patients but rare in patients with other GGE subsyndromes or under treatment with other recommended anti-seizure medication. Lamotrigine myoclonic epilepsy, juvenile, 2 Homo sapiens